Dr. Manoj Mahajan

Dr Manoj Mahajan is one of Rajasthan's most accomplished Medical Oncologists, with 22 years of clinical experience, 10,000+ cancer patients treated, 60,000+ chemotherapy sessions conducted, and 300+ cancer awareness camps reaching more than 20,000 people across the Mewar region.

He currently serves as Director of Medical Oncology at Paras Hospital, Shobhagpura, Udaipur, and as Senior Consultant Medical Oncology and Haematology at Sunrise Oncology Centre, Shobhagpura, Udaipur.

His academic foundation includes a Fellowship in Lymphoma and Myeloma at MD Anderson Cancer Center, Houston, Texas, USA (2019), the world's top-ranked cancer hospital, and a Summer School Fellowship at the International Agency for Research on Cancer (IARC), WHO, Lyon, France (2021).

He is also the founding force behind Cancer Care Clinic, Udaipur, and has previously served as Director of Oncology and Haematology at Pacific Medical College Hospital, Udaipur.

He is internationally recognised with the Rising Star Award by the Indo-American Cancer Association (IACA), Chicago, USA (2018), the Mewar Healthcare Achievers Award (2018 and 2019), the Principal Amritlal Parikh Award from ISMPO for Outstanding Cancer Care (2020), and was invited by IARC-WHO to Lyon, France for critical analysis of a multi-disease screening project.

He has successfully led Project Life, a collaborative initiative with IARC-WHO, Indo-American Cancer Association, and AIIMS Udaipur, using a five-pronged approach for cancer and non-communicable disease screening across the region.

Patients seeking expert chemotherapy, immunotherapy, targeted therapy, CAR-T cell therapy, lymphoma and myeloma treatment, breast, lung, blood, gynaecological, GI, and paediatric cancer care, or cancer screening and second opinion in Udaipur will find in Dr M Mahajan a senior oncologist combining international training with deep local impact.

He consults in English and Hindi, ensuring clear and comfortable conversations for patients and families navigating cancer diagnosis and treatment.

Specialty Areas and Treatments

Chemotherapy and Systemic Cancer Treatment in Udaipur

A high-volume practice with 60,000+ chemotherapy sessions administered:

• Chemotherapy for solid tumours and blood cancers
• Neoadjuvant chemotherapy (before surgery)
• Adjuvant chemotherapy (after surgery)
• Palliative chemotherapy for advanced and metastatic cancers
• Metronomic Chemotherapy (low-dose, long-duration) for reduced side effects and lower cost
• Side-effect management and supportive care during chemotherapy
• Day-care chemotherapy at Sunrise Oncology Centre and Paras Hospital

Cancer Immunotherapy

A signature area, with dedicated MD Anderson Fellowship training in immunotherapy and CAR-T cell therapy:

• Immune Checkpoint Inhibitor Therapy (PD-1, PD-L1, CTLA-4 inhibitors)
• Immunotherapy for Lung Cancer
• Immunotherapy for Kidney Cancer
• Immunotherapy for Head and Neck Cancers
• Immunotherapy for Melanoma
• Combination immunotherapy and chemotherapy protocols
• Antibody therapy including bispecific antibodies

CAR-T Cell Therapy

A rare and emerging sub-specialty, with MD Anderson-level exposure:

• CAR-T Cell Therapy evaluation and eligibility assessment
• CAR-T for Relapsed and Refractory B-Cell Lymphoma
• CAR-T for Multiple Myeloma (eligibility and referral)
• Post-CAR-T monitoring and toxicity management
• Counselling and second opinion for patients considering CAR-T cell therapy

Lymphoma and Myeloma Treatment

A dedicated sub-specialty, supported by a formal Fellowship at MD Anderson, Houston:

• Hodgkin Lymphoma (all stages)
• Non-Hodgkin Lymphoma (NHL) including diffuse large B-cell, follicular, mantle cell, and T-cell types
• Multiple Myeloma diagnosis and treatment
• Waldenstrom's Macroglobulinaemia
• Chronic Lymphocytic Leukaemia (CLL)
• Targeted therapy for lymphoma (BTK inhibitors, BCL-2 inhibitors)
• Stem Cell Transplant evaluation and coordination

Blood Cancer (Haematological Oncology)

• Acute Myeloid Leukaemia (AML) and Acute Lymphoblastic Leukaemia (ALL)
• Chronic Myeloid Leukaemia (CML) with targeted therapy (imatinib, dasatinib, nilotinib)
• Myelodysplastic Syndrome (MDS)
• Myeloproliferative Neoplasms (polycythaemia vera, essential thrombocythaemia, myelofibrosis)
• Bone Marrow Biopsy evaluation and coordination
• Haematological malignancy second opinion

Targeted Therapy and Precision Oncology

• Molecular Profiling and tumour genomic testing
• EGFR, ALK, ROS1, KRAS, BRAF, HER2 targeted therapy planning
• BRCA1/BRCA2 testing and PARP inhibitor therapy
• PARP inhibitors for ovarian cancer
• CDK4/6 inhibitors for breast cancer
• Precision oncology based on NGS (next-generation sequencing) results
• Coordination of pathology, molecular diagnostics, and radiology investigations

Breast Cancer Treatment

• HER2-positive Breast Cancer targeted therapy
• Hormone Receptor-Positive Breast Cancer endocrine therapy
• Triple Negative Breast Cancer (TNBC) immunotherapy and chemotherapy
• Metastatic Breast Cancer management
• Neoadjuvant and Adjuvant Breast Cancer Chemotherapy

Lung Cancer Treatment

• Non-Small Cell Lung Cancer (NSCLC) targeted therapy and immunotherapy
• Small Cell Lung Cancer (SCLC) management
• Stage IV and Metastatic Lung Cancer care
• Molecular testing for lung cancer treatment planning

Gastrointestinal Cancer Treatment

• Gastric (Stomach) Cancer
• Colon and Colorectal Cancer
• Liver Cancer (HCC) medical management
• Pancreatic Cancer
• Esophageal Cancer
• Gallbladder Cancer

Gynaecological Cancer Treatment

• Ovarian Cancer including PARP inhibitor therapy
• Cervical Cancer medical management
• Endometrial/Uterine Cancer
• Coordinated multidisciplinary gynae-onco care

Paediatric Cancer Treatment

A dedicated area of practice, with structured experience in childhood cancers:

• Paediatric Leukaemia (ALL, AML)
• Paediatric Lymphoma
• Wilms Tumour and Neuroblastoma medical management
• Paediatric solid tumour chemotherapy
• Long-term follow-up for childhood cancer survivors

Head and Neck Cancer Treatment

• Oral, Throat, Laryngeal, and Salivary Gland Cancers
• Immunotherapy for recurrent head and neck cancers
• Targeted and combination therapy

Palliative Care and Supportive Oncology

• Palliative chemotherapy in advanced cancer
• Pain Management and Palliative Care
• End-of-life care planning
• Symptom management (nausea, fatigue, pain)
• Quality of life-focused care
• Family and caregiver counselling

Cancer Screening and Prevention

A public health leadership area, including IARC-WHO Project Life implementation:

• Cervical Cancer Screening (Pap smear, HPV testing, HPV vaccination)
• Breast Cancer Screening (using innovative non-invasive techniques in collaboration with IARC-WHO)
• Oral Cancer Screening
• Cancer genetics and risk counselling
• Non-communicable disease screening (hypertension, diabetes, cervical, breast, oral cancer)
• Second opinion for cancer diagnosis and treatment plans

Conditions Commonly Treated

• All types of Lymphoma (Hodgkin and Non-Hodgkin)
• Multiple Myeloma
• Leukaemia (ALL, AML, CML, CLL)
• Breast, Lung, Ovarian, Cervical, Endometrial Cancer
• Gastric, Colorectal, Liver, Pancreatic, Gallbladder Cancer
• Head and Neck Cancers
• Paediatric Cancers
• Recurrent, Refractory, and Metastatic Cancers
• Hereditary Cancer Syndromes

Why Choose Dr Manoj Mahajan

• 10,000+ cancer patients treated across 22 years
• Fellowship in Lymphoma and Myeloma at MD Anderson Cancer Center, Houston, the world's top-ranked cancer hospital
• Fellowship at IARC-WHO, Lyon, France, reflecting rare global research exposure
• CAR-T cell therapy expertise, one of India's most advanced and rare oncology sub-specialties
• Multiple international and national awards including Rising Star Award (IACA Chicago 2018) and Principal Amritlal Parikh Award (ISMPO 2020)
• Implemented Project Life with IARC-WHO and AIIMS Udaipur for multi-disease screening

Credentials and Trust Signals

• MBBS from BJ Medical College and Sassoon Hospitals, Pune, Maharashtra (2004)
• DNB Internal Medicine from Kamalnayan Bajaj Hospital, Aurangabad, Maharashtra (2011)
• DNB Medical Oncology from Army Hospital (Research and Referral), New Delhi (2015)
• Fellowship in Lymphoma and Myeloma (Immunotherapy and CAR-T Cell Therapy) at MD Anderson Cancer Center, Houston, Texas, USA (2019)
• Summer School Fellowship (FIARC) at International Agency for Research on Cancer (IARC), WHO, Lyon, France (2021)

Maharashtra Medical Council Registration No. 3650 (since 2005)

Awards, Research and Community Outreach

• Rising Star Award, Indo-American Cancer Association (IACA), Chicago, USA (June 2018)
• Mewar Healthcare Achievers Award for outstanding contribution to Oncology in the Mewar region (2018 and 2019)
• Principal Amritlal Parikh Award, Indian Society of Medical and Paediatric Oncology (ISMPO), for Outstanding Work in Cancer Care (November 2020)
• Invited by IARC-WHO to Lyon, France for critical analysis of Project Life, a five-pronged non-communicable disease screening programme
• Project Life Implementation Lead in collaboration with IARC-WHO, Indo-American Cancer Association (IACA), and AIIMS Udaipur
• BREAST CANCER Screening Project using non-invasive "breast lightly" technique in collaboration with IARC-WHO
• International publications in cancer research
• Extensive contributions to paramedical training, cancer survivorship awareness, and public oncology education

Patient Experiences

Dr Manoj Mahajan has built deep patient trust across Udaipur and the Mewar region, consistently described as understanding, patient-focused, and thorough by verified patients.

One verified Google reviewer notes: "Dr Manoj Mahajan is the best doctor I have come across. The way he handles the patient is superb. He is very understanding and listens to your concerns. He takes time with the patient. I highly recommend him."

Patients particularly appreciate his ability to explain complex cancer treatment options clearly, personalised chemotherapy planning with focus on minimising side effects, and his calm, compassionate demeanour during emotionally challenging cancer journeys.

Current Hospital Affiliations and Past Experience

Dr Manoj Mahajan currently consults at:

• Paras Hospital, Shobhagpura, Udaipur – Director, Medical Oncology. Consultation timings: Monday to Saturday, 10:00 AM to 8:00 PM. Consultation fee: ₹850.
• Sunrise Oncology Centre, 1st Floor, Moda Shree Plaza, Near Ceremony Resort, Shobhagpura, Udaipur – Senior Consultant Medical Oncology and Haematology (Operational since September 2024)

Before his current roles, Dr Mahajan served at:

• Director, Oncology and Haematology at Pacific Medical College Hospital, Udaipur
• Consultant Medical Oncologist at GBH American Hospital, Udaipur
• Founder, Cancer Care Clinic, Udaipur
• Research Fellow, IARC-WHO, Lyon, France (2021)
• Fellowship in Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, Texas, USA (2019)

Book an Appointment with Dr Manoj Mahajan

Book a priority appointment with Dr Manoj Mahajan, Director of Medical Oncology at Paras Hospital, Udaipur, on HexaHealth to confirm your slot in minutes.